Source: http://feedproxy.google.com/~r/HealthBusinessBlog/~3/R4UQx6c7xGQ/
Monday, 28 November 2011
Lipitor: How Pfizer hopes to slow the decline
By all rights, Pfizer’s Lipitor revenues should drop like a stone once the drug loses US patent protection at the end of the month. And I think it’s likely that over time prescription Lipitor sales will whither away. Pfizer’s original plan was to replace Lipitor sales with those of torcetrapib, a new and improved drug [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment